12/24
12:37 am
rhhby
Is FDA's Fast Subcutaneous Lunsumio VELO Approval Reshaping the Investment Case For Roche (SWX:ROG)? [Yahoo! Finance]
Low
Report
Is FDA's Fast Subcutaneous Lunsumio VELO Approval Reshaping the Investment Case For Roche (SWX:ROG)? [Yahoo! Finance]
12/22
01:14 am
rhhby
FDA approves Roche's Lunsumio VELO™ for subcutaneous use in relapsed or refractory follicular lymphoma [Yahoo! Finance]
Medium
Report
FDA approves Roche's Lunsumio VELO™ for subcutaneous use in relapsed or refractory follicular lymphoma [Yahoo! Finance]
12/22
01:00 am
rhhby
FDA Approves Genentech’s Lunsumio VELO™ for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma
Medium
Report
FDA Approves Genentech’s Lunsumio VELO™ for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma
12/20
09:41 pm
rhhby
Roche CEO points to higher future drug prices in Switzerland after US deal [Yahoo! Finance]
Medium
Report
Roche CEO points to higher future drug prices in Switzerland after US deal [Yahoo! Finance]
12/20
09:41 pm
rhhby
Does Roche Still Offer Value After a 35.9% Rally and New Oncology Partnerships? [Yahoo! Finance]
Medium
Report
Does Roche Still Offer Value After a 35.9% Rally and New Oncology Partnerships? [Yahoo! Finance]
12/20
04:45 pm
rhhby
Roche CEO points to higher future drug prices in Switzerland after US deal [Yahoo! Finance Canada]
Medium
Report
Roche CEO points to higher future drug prices in Switzerland after US deal [Yahoo! Finance Canada]
12/19
04:35 pm
rhhby
Nine Drugmakers Strike Deals With Trump, With More to Come [Yahoo! Finance Canada]
Low
Report
Nine Drugmakers Strike Deals With Trump, With More to Come [Yahoo! Finance Canada]
12/19
03:27 pm
rhhby
Year in Review: Pharmaceuticals industry continues ascent [Yahoo! Finance]
Low
Report
Year in Review: Pharmaceuticals industry continues ascent [Yahoo! Finance]
12/19
02:50 pm
rhhby
Genentech Announces Agreement With U.S. Government [Yahoo! Finance]
Low
Report
Genentech Announces Agreement With U.S. Government [Yahoo! Finance]
12/19
02:28 pm
rhhby
Genentech Announces Agreement With U.S. Government
Low
Report
Genentech Announces Agreement With U.S. Government
12/17
05:52 pm
rhhby
Ulcerative Colitis Market Poised for Strong Expansion During the Forecast Period (2025-2034) Driven by Biologic and Novel Therapy Adoption Landscape | DelveInsight [Yahoo! Finance]
Low
Report
Ulcerative Colitis Market Poised for Strong Expansion During the Forecast Period (2025-2034) Driven by Biologic and Novel Therapy Adoption Landscape | DelveInsight [Yahoo! Finance]
12/16
08:30 am
rhhby
Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities
Low
Report
Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities
12/16
02:17 am
rhhby
Calluna Pharma Announces the Appointment of Gijs van den Brink, MD, PhD, as Independent Director [Yahoo! Finance]
Low
Report
Calluna Pharma Announces the Appointment of Gijs van den Brink, MD, PhD, as Independent Director [Yahoo! Finance]
12/15
08:33 am
rhhby
Manifold Bio Expands Leadership Team to Drive its AI + In Vivo Targeted Biologics Platform [Yahoo! Finance]
Low
Report
Manifold Bio Expands Leadership Team to Drive its AI + In Vivo Targeted Biologics Platform [Yahoo! Finance]
12/12
05:05 am
rhhby
Zealand Pharma and OTR to develop metabolic disease therapeutics [Yahoo! Finance]
Low
Report
Zealand Pharma and OTR to develop metabolic disease therapeutics [Yahoo! Finance]
12/11
08:13 am
rhhby
FDA proposes allowing sunscreen ingredient already used in Europe and Asia [MSNBC.com]
Low
Report
FDA proposes allowing sunscreen ingredient already used in Europe and Asia [MSNBC.com]
12/11
01:37 am
rhhby
Roche expands automated mass spectrometry menu with antibiotics drug monitoring CE mark approval offering industry's broadest in vitro diagnostic menu [Yahoo! Finance]
Medium
Report
Roche expands automated mass spectrometry menu with antibiotics drug monitoring CE mark approval offering industry's broadest in vitro diagnostic menu [Yahoo! Finance]
12/10
08:54 am
rhhby
Genentech's Giredestrant Reduced Risk of Invasive Disease Recurrence or Death by 30% in ER-positive Early-Stage Breast Cancer [Yahoo! Finance]
Low
Report
Genentech's Giredestrant Reduced Risk of Invasive Disease Recurrence or Death by 30% in ER-positive Early-Stage Breast Cancer [Yahoo! Finance]
12/10
08:20 am
rhhby
Genentech’s Giredestrant Reduced Risk of Invasive Disease Recurrence or Death by 30% in ER-positive Early-Stage Breast Cancer
Low
Report
Genentech’s Giredestrant Reduced Risk of Invasive Disease Recurrence or Death by 30% in ER-positive Early-Stage Breast Cancer
12/10
08:05 am
rhhby
Roche (OTCMKTS:RHHBY) had its "buy" rating reaffirmed by analysts at HSBC Holdings plc.
Medium
Report
Roche (OTCMKTS:RHHBY) had its "buy" rating reaffirmed by analysts at HSBC Holdings plc.
12/9
08:11 am
rhhby
Roche (OTCMKTS:RHHBY) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
Roche (OTCMKTS:RHHBY) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
12/8
04:30 pm
rhhby
Genentech Presents Lunsumio Data Showing Potential Across Earlier Treatment Lines in Indolent and Aggressive Lymphomas
Low
Report
Genentech Presents Lunsumio Data Showing Potential Across Earlier Treatment Lines in Indolent and Aggressive Lymphomas
12/8
09:16 am
rhhby
Roche (OTCMKTS:RHHBY) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating.
Low
Report
Roche (OTCMKTS:RHHBY) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating.
12/2
12:08 pm
rhhby
Roche (OTCMKTS:RHHBY) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Roche (OTCMKTS:RHHBY) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.
12/2
01:15 am
rhhby
Roche receives FDA clearance with CLIA waiver and CE Mark for its first point-of-care test for diagnosing Bordetella infections, including whooping cough (pertussis) [Yahoo! Finance]
Low
Report
Roche receives FDA clearance with CLIA waiver and CE Mark for its first point-of-care test for diagnosing Bordetella infections, including whooping cough (pertussis) [Yahoo! Finance]